Isodiol International Inc. Applauds the World Health Organization on Its Recommendation That Pure CBD Should Not Be Scheduled Within International Drug Control Conventions

August 17, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”),a global CBD leader and innovator, applauds the World Health Organization’s (WHO) historic recommendation, at the conference in Geneva, that pure CBD should not be scheduled within the International Drug Control Conventions. Some key findings from the WHO:…

Read More

ISODIOL INTERNATIONAL INC. APPOINTS BARINDER RASODE TO ITS ADVISORY BOARD

August 14, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is pleased to announce the appointment of Barinder Rasode to its advisory board. She will be focused on assisting the Company with its advocacy to various governmental and non-governmental…

Read More

Isodiol International Inc. Announces Partnership Between ISO-Sport and ALTIS, an Elite Training Environment for Athletes & Coaches

August 7, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD leader and innovator is pleased to announce that Iso-Sport has entered into an agreement with ALTIS LLC (“Altis”), an Arizona based company that was built to bring Track & Field back to global prominence…

Read More

Marvin Washington Tackles Cannabis On The Green Rush Podcast

On this week’s episode of The Green Rush podcast, hosts Anne Donohoe and Lewis Goldberg spend time with Super Bowl champion and cannabis educator and activist Marvin Washington. After an impressive 11 year career on the NFL, Marvin has truned his attention to the cannabis industry as an entrepreneur, an educator, a spokesperson and activist.…

Read More

ISODIOL INTERNATIONAL INC. ANNOUNCES LETTER OF INTENT FOR ONGOING SUPPLY OF PHARMACEUTICAL GRADE CANNABIDIOL TO PURE GLOBAL CANNABIS INC. FROM BSPG LABORATORIES, LTD.

August 2, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader specializing in the development of pharmaceutical drug deliveries, health and wellness products and now supporting the pharmaceutical industry at large with BSPG Laboratories, LTD. recently approved CBD as an Active…

Read More

Isodiol International Inc. Introduces Isoderm Direct Effects Technology Nationally Via PBS Television

July 31, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods, and the manufacturing of pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in Finished Pharmaceutical Products…

Read More

Isodiol International Inc. Finalizes Share Consolidation

July 24, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical…

Read More

Isodiol International Inc. Applauds the FDA’s Decision to Recognize the Medical Benefits of CBD at Higher Concentrations and Announces Corporate Restructure

June 27, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs), applauds the FDA’s decision on the long-anticipated approval of GW Pharmaceutical’s (NASDAQ:…

Read More

Isodiol International, Inc. Announces May 2018 Revenues and Corporate Update

June 11, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in…

Read More
CBD in the world of boxing

CBD In The World Of Boxing

Both amateur and professional boxers are turning to CBD to help them in their training, fighting, and recovery regimes. We attempt to unpick the benefits of CBD for boxers and other sportspeople here. But First, Let’s Understand What Is CBD CBD is a powerful molecule that is produced by hemp or cannabis plants. It stands…

Read More
Does CBD come from hemp & how is it made?

CBD From Hemp: How It’s Made?

We’ve all heard of CBD’s supposed benefits to physical and mental health, and to general well-being. But what exactly is it, and how is CBD made from hemp seed? CBD What It Is CBD is a phytochemical – a compound made by plants. It has been taking the medical and wellness world by storm for…

Read More

Isodiol International Inc. Announces Closing of Strategic Non-Brokered Offering for Total Proceeds of $18 Million

May 28, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, announces the closing…

Read More

ISODIOL INTERNATIONAL INC. ANNOUNCES LETTER OF INTENT TO SUPPLY 99.5%+ CANNABIDIOL ISOLATE TO SUNDIAL

May 24, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, is pleased to…

Read More